Researchers at the University of Minnesota and Mayo Clinic have received a $1.35 million grant to study a form of blood cancer called myelodysplastic syndrome.  The grant from the Minnesota Partnership for Biotechnology and Medical Genomics is on top of $2.5 million the university received last year from the National Institutes of Health to study the disease.

MPR by Elizabeth Dunbar

Tags: Cancer, Hematology, Minnesota Partnership for Biotechnology and Medical Genomics, Myelodysplastic Syndrome, Research, University of Minnesota